Hospital News and Research

RSS

Trial of Quadramet (153 Samarium-lexidronam) in combo with Velcade shows positive results

Quadramet (153 Samarium-lexidronam) is a radioactive medication that targets the bone, specifically bone cancer, and is used to treat pain caused by cancer that has metastasized or spread to the bone.

15 Feb 2009

Exercise lowers risk of colon cancer

An ambitious new study has added considerable weight to the claim that exercise can lower the risk for colon cancer.

15 Feb 2009

New test for mysterious metabolic diseases

Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells' fuel-burning mechanism.

15 Feb 2009

Personal digital assistants used to track tuberculosis data

For patients who have drug-resistant forms of tuberculosis, it's critical to monitor the disease as closely as possible.

11 Feb 2009

Study on ustekinumab for treatment of psoriatic arthritis published

A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).

11 Feb 2009

Discovery of new mechanism that tumours use to stimulate growth of blood vessels that feed them

The development of cancerous tumours is highly dependent on the nutrients the tumours receive through the blood.

11 Feb 2009

Groundbreaking study reveals how enzymes in the cell cooperate to make fat

These enzymes are integrated into a single molecular complex known as fatty acid synthase. This complex is regarded as a potential target for developing new anti-obesity and anti-cancer drugs.

11 Feb 2009

Girls growing up with heroin-addicted parent more resilient than boys

Growing up with a heroin-addicted parent exposes children to a variety of detrimental experiences before the age of 18 and new research indicates that girls are four times more resilient than boys in overcoming such adverse events.

11 Feb 2009

Bone marrow transplant patients may benefit from new immune research

Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs.

11 Feb 2009

Abbott receives FDA clearance for new CELL-DYN Emerald hematology instrument

Abbott has announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald.

11 Feb 2009

Race and ethnicity affect use of hospice services among patients with advanced cancer

Race and ethnicity appear to have an effect on whether a patient with terminal cancer uses hospice care services, according to a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

10 Feb 2009

Postnatal psychosis more common in older first-time mothers

Women who give birth for the first time after the age of 35 run a greater risk than younger first-time mothers of suffering a psychosis in the months after delivery.

10 Feb 2009

Most coordinated care programs for Medicare beneficiaries do not show benefit

Only 2 of 15 Medicare programs designed to improve care and costs for patients with chronic illnesses resulted in reduced hospital admissions, and none of the programs generated net savings, according to a study in the February 11 issue of JAMA.

10 Feb 2009

Cytokines lead to neurological and cognitive abnormalities and changes in heart rhythm in patients with cirrhosis

Liver cirrhosis is the seventh leading cause of death in the United States, taking 25,000 lives per year.

10 Feb 2009

First-time mothers at a greater risk of psychosis in the month following childbirth

A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.

10 Feb 2009